Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB26FQATQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,950
Award facts
- Contract value 100% obligated
- $7,949.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,949.53 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 23, 2025. This non-competitive, firm fixed-price delivery order was issued on October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used for cholesterol management in patients with cardiovascular disease, representing a specialty pharmaceutical product within the company's broader pharmaceutical distribution portfolio.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that provides global pharmaceutical support for military healthcare programs. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical devices to support Defense Health Agency and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders under this IDC demonstrates its capability to fulfill federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FQATQ?
SPE2DB26FQATQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FQATQ worth?
The government has obligated $7,950 on SPE2DB26FQATQ.
Is contract SPE2DB26FQATQ an order under another contract?
Yes. SPE2DB26FQATQ is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB26FQATQ competed?
The extent of competition for SPE2DB26FQATQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award